If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Guidelines and literature
Oncology and PET/CT Gallery
- 2023
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?
Delgado Bolton, R.C, Calapaquí Terán A.K., Herrmann, K., Fanti, S., Giammarile, F., Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?, Clin Nucl Med. 48(4) (2023) 318-319. doi:10.1097/RLU.0000000000004602
- 2023
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer
Delgado Bolton, R.C., Calapaquí Terán, A.K., Gómez Román, J.J., Treglia, G., Giammarile, F., A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer [published online ahead of print, 2023 Mar 24], Eur J Nucl Med Mol Imaging (2023) 10.1007/s00259-023-06213-4. doi:10.1007/s00259-023-06213-4.
- 2023
Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
Czibor, S., Carr, R., Redondo, F., Auewarakul, C.U., Cerci, J. J., Paez, D., Fanti, S., Györke, T., Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients, Nucl Med Commun. (2023).
- 2023
Prone versus Supine FDG PET/CT in the Staging of Breast Cancer
Nassar, L., Kassas, M., Abi-Ghanem, A.S., El-Jebai, M., Al-Zakleet, S., Baassiri, A.S., Naccoul, R.A., Barakat, A., Tfayli, A., Assi, H., Berjawi, G., Estrada-Lobato, E., Giammarile, F., Vinjamuri, S., Haidar M., Prone versus Supine FDG PET/CT in the Staging of Breast Cancer, Diagnostics (Basel) 13(3) (2023) 367.
- 2022
Sentinel lymph node methods in breast cancer
GIAMMARILE, F. et al., Sentinel Lymph Node Methods in Breast Cancer, Seminars in Nuclear Medicine, Vol. 52, Elsevier BV (2022) pp. 551–560.
- 2022
Sentinel node biopsy imaging in breast cancer: Scatter reduction using 3D printed lead shields
CA–ETE-SÁNCHEZ, F.M. et al., Sentinel Node Biopsy Imaging in Breast Cancer, Clinical Nuclear Medicine, Vol. 47, Ovid Technologies (Wolters Kluwer Health) (2022) pp. 618–624
- 2022
Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine
MIKHAIL LETTE, M.N. et al., Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine, JCO Global Oncology, American Society of Clinical Oncology (ASCO) (2022)
- 2022
Radioguided Surgery for Malignant Melanoma
VIDAL-SICART, S., ORSINI, F., GIAMMARILE, F., MARIANI, G., VALDÉS OLMOS, R.A., Radioguided Surgery for Malignant Melanoma, Nuclear Oncology, Springer International Publishing (2022) pp. 1–38
- 2022
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.
HERRMANN, K. et al., Joint EANM, SNMMI and IAEA Enabling Guide: How to Set up a Theranostics Centre, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Springer Science and Business Media LLC (2022) pp. 2300–2309
- 2022
VALIDATION OF CONVOLUTIONAL NEURAL NETWORK FOR FAST DETERMINATION OF WHOLE-BODY METABOLIC TUMOR BURDEN IN PEDIATRIC LYMPHOMA
ETCHEBEHERE, E. et al., VALIDATION OF CONVOLUTIONAL NEURAL NETWORK FOR FAST DETERMINATION OF WHOLE-BODY METABOLIC TUMOR BURDEN IN PEDIATRIC LYMPHOMA, Journal of Nuclear Medicine Technology, Society of Nuclear Medicine (2022) p. jnmt.121.262900
- 1 March 2022
In conversation with Diana Paez
Paez, D., In Conversation With Dr Diana Paez, C.C. Challenge, Editor. 2022, City Cancer Challenge
- 2022
Childhood cancer inequalities in the WHO European region
WORLD HEALTH ORGANIZATION, Regional Office for, E., Childhood cancer inequalities in the WHO European Region, Copenhagen: World Health Organization, Regional Office for Europe (2022)
- 2022
New Biomarkers With Prognostic Impact Based on Multitracer PET/CT Imaging in Neuroendocrine Neoplasms: The Light Leading Out of the Darkness in Challenging Tumors
DELGADO BOLTON, R.C., CALAPAQUÍ TERÁN, A.K., FANTI, S., GIAMMARILE, F., New Biomarkers With Prognostic Impact Based on Multitracer PET/CT Imaging in Neuroendocrine Neoplasms, Clinical Nuclear Medicine, Vol. 47, Ovid Technologies (Wolters Kluwer Health) (2022) pp. 219–220
- 2022
Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America
GIAMMARILE, F. et al., Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America, Seminars in Nuclear Medicine, Vol. 52, Elsevier BV (2022) pp. 31–40
- 2021
Prognostic Parameters on Baseline and Interim F-18-FDG-PET/CT in Diffuse Large B-cell Lymphoma Patients
Prognostic Parameters on Baseline and Interim F-18-FDG-PET/CT in Diffuse Large B-cell Lymphoma Patients 2021 S. Czibor, R. Carr, F. Redondo, C. Gorospe, C. Auewarakul, J. Cerci, D. Paez, S. Fanti and T. Györke DOI: 10.21203/rs.3.rs-958512/v1
- 2021
The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions
BOLTON, R.C.D., TERÁN, A.K.C., PELLET, O., FERRERO, A., GIAMMARILE, F., The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions, Clin Nucl Med 46 11 (2021) 906-907.
- 2021
Development of nuclear medicine in Africa
GRIGORYAN, A. et al., Development of Nuclear Medicine in Africa, Clinical and Translational Imaging, Vol. 10, Springer Science and Business Media LLC (2021) pp. 101–111
- 2021
Comparison [68Ga]FAPİ-46 PET/CT and [131I] SPECT/CT findings after ablation therapy with high-activity 131-I therapy of metastatic papillary thyroid cancer patients: Two case reports
NOVRUZOV, F., et al., Comparison [68Ga]FAPİ-46 PET/CT and [131I] SPECT/CT findings after ablation therapy with high-activity 131-I therapy of metastatic papillary thyroid cancer patients: Two case reports, (2021)
- 2021
Diagnostic performance and clinical impact of (68)Ga-PSMA-11 imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study)
CERCI, J.J., et al., Diagnostic performance and clinical impact of (68)Ga-PSMA-11 imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study), J Nucl Med (2021)
- 2021
EANM guideline on the role of 2-[(18)F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the ACNM, SNMMI and IAEA
DELGADO BOLTON, R.C., et al., EANM guideline on the role of 2-[(18)F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA), Eur J Nucl Med Mol Imaging (2021)
- 1 of 11
- next ›